Plus Therapeutics receives Nasdaq deficiency notice for late Q1 10-Q filing

PLUS THERAPEUTICS, INC.

Received Nasdaq notice on May 21, 2025 for missing Q1 2025 Form 10-Q filing deadline.
Must submit a plan to regain compliance by July 21, 2025.
If plan accepted, Nasdaq can grant exception until November 17, 2025 to file.
No immediate effect on PSTV stock listing on Nasdaq.
Company expects to return to normal filing cadence for remainder of 2025.

item 3.01item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.